Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

791 results
Display

Erratum to ‘KASL clinical practice guidelines for management of chronic hepatitis B’ [Clin Mol Hepatol 2022;28:276-331]

The Korean Association for the Study of the Liver (KASL)

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Erratum to ‘History and future of hepatitis B virus control in South Korea’ [Clin Mol Hepatol 2021;27:620-622]

Kim DY

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Erratum to ‘Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?’ [Clin Mol Hepatol 2023;29:367-370]

Oh JH, Sinn DH

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Erratum to ‘Correspondence on Letter regarding “Evidencebased hyponatremia management in liver disease”’ [Clin Mol Hepatol 2023;29:1048-1049]

Baek SH, Ryu JY, Kim S

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Congratulatory remarks

Bae SH

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Special thanks

Kim SU

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hyperammonemic encephalopathy: An unusual presentation of fibrolamellar hepatocellular carcinoma

Thakral N, Simonetto

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Erratum

No authors listed

On page 358, There was an error in the legend of Figure 2. On page 373, There was an error in the Table 3.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Letter regarding “Risk factors in nonalcoholic fatty liver disease”

Pratap A, More U, Phalak P, Deshmukh A

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Phosphoinositide 3-kinase inhibitors are effective therapeutic drugs for the treatment of hepatocellular carcinoma?

Park JS, Bae SH

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The management of polycystic liver disease by tolvaptan

Takenaka T, Miura S, Kitajima M

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Elimination of hepatitis C: What would be the practical approach?

Yim HJ

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A challenge in distinguishing between acute hepatitis Band acute exacerbation of chronic hepatitis B

Baek YH

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adding to the confusion in more than just the name

George J

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Microbiome and metabolomics in alcoholic liver disease

Ganesan R, Suk KT

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma

Song J

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Preface

Kim SU

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-term prognosis and management of hepatocellular carcinoma after curative treatment

Nishida N

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diagnosis of hepatocellular carcinoma: Which MRI contrast agent? Which diagnostic criteria?

Kim SY

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
History and future of hepatitis B virus control in South Korea

Kim DY

CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr